Learn how GlaxoSmithKline gained internal buy-in to invest in a Covance technology solution to improve operational performance and accelerate decision making.

Running a trial to test new antimicrobials for Hospital-Acquired Bacterial Pneumonia and Ventilator-Acquired Bacterial Pneumonia (HABP/VABP) is extremely challenging for sponsors and sites.

Chronic Kidney Disease (CKD) is a global epidemic yet is widely under-recognized. Diabetes, the leading cause of CKD, and the burden of associated cardiovascular disease (CVD), contributes to CKD morbidity and mortality.

In this presentation, we will discuss different technical approaches that can be used to assess receptor occupancy (RO) by flow cytometry and explore the various pros and cons of each approach. Finally, we review the challenges that can be encountered during RO assay development, validation and implementation for multi-center clinical trials.

This webinar provides a comprehensive overview of cardiorenal syndrome, risk factors and the use of the clinical laboratory for supporting risk prediction, detection and disease management.

This webinar showcases how RWE and data analytics can be leveraged for evidence generation and value demonstration. Leading industry SMEs and speakers provide their unique perspectives on the topic and discuss how life sciences organization are securely and efficiently driving their real world evidence initiatives.